Company Filing History:
Years Active: 2005
Title: Gabriele Schramm: Innovator in Allergy Therapy
Introduction
Gabriele Schramm is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of immunotherapy, particularly in the area of allergy treatment. His innovative work focuses on developing modified allergens that can improve the quality of life for individuals suffering from pollen allergies.
Latest Patents
Gabriele Schramm holds a patent for "Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same." This invention relates to modified recombinant allergen mutants derived from natural raw materials, such as pollen. These modified allergens stimulate lymphocytes from allergic patients to proliferate and synthesize cytokines. Importantly, they exhibit a markedly diminished ability to bind to IgE antibodies present in the serum of T lymphocyte donors. This characteristic allows for a more effective and specific allergy therapy.
Career Highlights
Gabriele Schramm is associated with Merck Patent Gesellschaft MIT, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for allergy sufferers, showcasing his commitment to improving healthcare through scientific advancements.
Collaborations
Gabriele has collaborated with notable colleagues, including Helga Kahlert and Hans-Thomas Stüwe. These partnerships have contributed to the success of his research and the development of his patented technologies.
Conclusion
Gabriele Schramm's contributions to the field of allergy therapy through his innovative patents highlight his role as a leading inventor in this area. His work not only advances scientific knowledge but also offers hope for better treatment options for those affected by allergies.